Centre takes action against 76 drug companies for shoddy products

New Delhi, 30/3: The Centre cancelled or suspended licences of some domestic drug companies as part of action taken against 76 pharmaceutical firms this month for selling adulterated or fake products, a government source said on Thursday.

 

 

India is known as the ‘pharmacy of the world’ and its pharmaceuticals exports have more than doubled over the past decade to Rs 2 lakh crore ($24.5 billion) in 2021-22.

 

But that image has been dented by the death of at least 70 children in Gambia and 19 children in Uzbekistan last year linked to drugs made by India-based pharmaceutical companies

Comments are closed.